title: Updated product label allows home administration of omacetaxine mepesuccinate.
authors.affiliation: Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
authors.forename: Ann Q
authors.initials: AQ
authors.lastname: Shen
authors.affiliation: Teva Branded Pharmaceutical Products R&D, Inc., Frazer, Pennsylvania, USA.
authors.forename: Mihaela
authors.initials: M
authors.lastname: Munteanu
authors.affiliation: Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
authors.forename: Hanna Jean
authors.initials: HJ
authors.lastname: Khoury
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005260:Female; D006248:Harringtonines / Q000627:therapeutic use*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D006248:Harringtonines